SLC4A1AP

Across TCGA pan-cancer cohorts, SLC4A1AP mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of SLC4A1AP’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where SLC4A1AP mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types SLC4A1AP is over-expressed in tumor.

COAD, CCRCC, and HNSC are the cancer types where SLC4A1AP tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC4A1AP mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	III,IV	+0.503	<.001	12	view →
CCRCC	All	IV	+0.185	<.001	12	view →
HNSC	Male	IV	+0.476	<.001	11	view →
LUAD	Male	III,IV	+0.415	<.001	9	view →
LSCC	Female	II,III,IV	+0.638	<.001	8	view →
OV	All	All	+0.354	.011	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

SLC4A1AP–COAD

Open the COAD breakdown →